Effect of self-monitoring intervention for Palliative cancer patients : a randomized controlled trial

Effect of self-monitoring intervention for Palliative cancer patients : a randomized controlled trial - Effect of self-monitoring intervention for Palliative cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025322

Enrollment

200

Registered

2016-12-20

Start date

2015-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malingant disease

Interventions

No intervention QOL self-monitoring intervention Every day 3 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Cancer patients 2.General condition is good enough to participate in this study 3.Predicting prognosis:>= 1 month

Exclusion criteria

Exclusion criteria: Severe cognitive dysfunction Severe psychiatric disorder

Design outcomes

Primary

Measure	Time frame
QOL (EORTC QLQ-C-Pal) baseline, 1 weeks, 2 weeks	—

Secondary

Measure	Time frame
QOL (FACIT-Pal),Anxiety and Depression baseline, 1 weeks, 2 weeks	—

Countries

Japan

Contacts

Public ContactAyako Matsuda

Teikyo University School of Medicine Department of Hygiene and Public Health

amatsuda@med.teikyo-u.ac.jp03-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026